A Clinical Trial of STP0404 in Adults With HIV-1 Infection
Public ClinicalTrials.gov record NCT05869643. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2a, Randomized, Double-Blinded, Placebo-Controlled, Multicenter Study to Investigate the Antiviral Effect, Safety, Tolerability, and Pharmacokinetics of STP0404 in Adults With HIV-1 Infection
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to evaluate the antiviral effect, safety, tolerability, and pharmacokinetics of STP0404 in adult participants living with Human Immunodeficiency Virus Type 1 (HIV-1) infection.
Study identification
- NCT ID
- NCT05869643
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 25 participants
Conditions and interventions
Conditions
Interventions
- Low-dose STP0404 (Pirmitegravir) Drug
- Medium-dose STP0404 (Pirmitegravir) Drug
- High-dose STP0404 (Pirmitegravir) Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 65 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 22, 2023
- Primary completion
- Apr 24, 2026
- Completion
- May 5, 2026
- Last update posted
- May 7, 2026
2023 – 2026
United States locations
- U.S. sites
- 13
- U.S. states
- 7
- U.S. cities
- 12
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Kaiser Permenente Los Angeles Medical Center | Los Angeles | California | 90027 | — |
| Ruane Clinical Research, Inc. | Los Angeles | California | 90036 | — |
| Midway Immunology and Research Center | Ft. Pierce | Florida | 34982 | — |
| Schiff Center for Liver Diseases/University of Miami | Miami | Florida | 33136-2107 | — |
| Orlando Immunology Center | Orlando | Florida | 32803 | — |
| USF Health South Tampa Center for Advanced Healthcare | Tampa | Florida | 33602-3511 | — |
| Be Well Medical Center | Berkley | Michigan | 48072 | — |
| Saint Michael's Medical Center | Newark | New Jersey | 07102 | — |
| South Jersey Infectious Disease | Somers Point | New Jersey | 08244 | — |
| North Shore University Hospital | Manhasset | New York | 11030-3816 | — |
| Atrium Health Wake Forest Baptist Medical Center - PPDS | Winston-Salem | North Carolina | 27157 | — |
| St Hope Foundation, Inc | Bellaire | Texas | 77401 | — |
| North Texas Infectious Diseases Consultants, P.A. | Dallas | Texas | 75246 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Recently updated HIV-1-infection trials
Other public records listing HIV-1-infection. Sorted by last update posted; newest first. Not a recommendation.
- NCT07719491: Study of GS-0415 and How It Works in People With HIV Recruiting
- NCT07698600: A Clinical Trial to Look at the Safety and Immune Responses of the RNA-based Vaccine BNT168 in Adults Living With or Without HIV Recruiting
- NCT07708727: Study of an Injectable Regimen of GS-3242 With Lenacapavir Compared to Biktarvy in People New to HIV-1 Treatment Recruiting
- NCT07683000: Study of Lenacapavir, Teropavimab, and Zinlirvimab in Virologically Suppressed Adults With HIV-1 on Stable Oral Treatment Regimens Recruiting
- NCT03729778: Impact of HIV-1 and Aging on Mucosal Vaccine Responses Active, not recruiting
- NCT05459077: Addressing Barriers to Anti-hypertensive Medication Adherence Among PLWH Who Have Achieved Viral Suppression Not yet recruiting
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05869643, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 7, 2026 · Synced Sep 1, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT05869643 live on ClinicalTrials.gov.